Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
76.33
-0.88 (-1.14%)
Jan 16, 2026, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Analyst Ratings
Total Analysts
22
Consensus Rating
Strong Buy
Price Target
$83.64
Upside
+9.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $100 | Buy | Maintains | $82 → $100 | +31.01% | Jan 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $95 | Buy | Maintains | $82 → $95 | +24.46% | Dec 17, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $85 → $100 | Buy | Maintains | $85 → $100 | +31.01% | Dec 15, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $86 → $97 | Strong Buy | Maintains | $86 → $97 | +27.08% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +44.11% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $77 | Buy | Maintains | $70 → $77 | +0.88% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $59 → $99 | Strong Buy | Maintains | $59 → $99 | +29.70% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +23.15% | Oct 30, 2025 |
| Barclays | Barclays | Buy Maintains $80 → $95 | Buy | Maintains | $80 → $95 | +24.46% | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $95 → $100 | Strong Buy | Maintains | $95 → $100 | +31.01% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +7.43% | Oct 30, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $85 → $89 | Strong Buy | Reiterates | $85 → $89 | +16.60% | Oct 30, 2025 |
| Needham | Needham | Strong Buy Maintains $78 → $90 | Strong Buy | Maintains | $78 → $90 | +17.91% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $86 → $90 | Buy | Maintains | $86 → $90 | +17.91% | Oct 16, 2025 |
| Needham | Needham | Strong Buy Maintains $70 → $78 | Strong Buy | Maintains | $70 → $78 | +2.19% | Oct 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $84 → $90 | Buy | Maintains | $84 → $90 | +17.91% | Oct 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.